Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction
Allergan plc announces that, as expected, Allergan and AbbVie have each received a Request for Additional Information and Documentary Material (Second Request) from the US Federal Trade Commission (FTC) in connection with AbbVie’s pending acquisition of Allergan.
